TR201909052T4 - Deferasiroks içeren suda dağılabilen tablet formülasyonu. - Google Patents

Deferasiroks içeren suda dağılabilen tablet formülasyonu. Download PDF

Info

Publication number
TR201909052T4
TR201909052T4 TR2019/09052T TR201909052T TR201909052T4 TR 201909052 T4 TR201909052 T4 TR 201909052T4 TR 2019/09052 T TR2019/09052 T TR 2019/09052T TR 201909052 T TR201909052 T TR 201909052T TR 201909052 T4 TR201909052 T4 TR 201909052T4
Authority
TR
Turkey
Prior art keywords
water dispersible
formulation containing
dispersible tablet
tablet formulation
deferasirox
Prior art date
Application number
TR2019/09052T
Other languages
English (en)
Turkish (tr)
Inventor
Ceren Karabulut Tutku
Çi̇fter Ümi̇t
Türkyilmaz Ali̇
Yildirim Edi̇z
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Publication of TR201909052T4 publication Critical patent/TR201909052T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR2019/09052T 2014-05-20 2015-05-18 Deferasiroks içeren suda dağılabilen tablet formülasyonu. TR201909052T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR201405598 2014-05-20

Publications (1)

Publication Number Publication Date
TR201909052T4 true TR201909052T4 (tr) 2019-07-22

Family

ID=52003033

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/09052T TR201909052T4 (tr) 2014-05-20 2015-05-18 Deferasiroks içeren suda dağılabilen tablet formülasyonu.

Country Status (5)

Country Link
EP (1) EP2946771B1 (es)
ES (1) ES2734675T3 (es)
PL (1) PL2946771T3 (es)
PT (1) PT2946771T (es)
TR (1) TR201909052T4 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018208242A1 (en) * 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
TR201722910A2 (tr) * 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW533205B (en) 1996-06-25 2003-05-21 Novartis Ag Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition
GB0408078D0 (en) 2004-04-08 2004-05-12 Novartis Ag Organic compounds
WO2007045445A1 (en) 2005-10-19 2007-04-26 Novartis Ag Dispersible tablets comprising deferasirox
EP2062572A1 (en) * 2007-11-19 2009-05-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions
WO2010035282A1 (en) * 2008-09-24 2010-04-01 Matrix Laboratories Limited Pharmaceutical compositions comprising deferasirox
TR201103691A2 (tr) 2011-04-15 2011-08-22 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Deferasiroks dağılabilir tablet formülasyonu.

Also Published As

Publication number Publication date
EP2946771B1 (en) 2019-03-20
PT2946771T (pt) 2019-06-27
EP2946771A1 (en) 2015-11-25
PL2946771T3 (pl) 2019-10-31
ES2734675T3 (es) 2019-12-11

Similar Documents

Publication Publication Date Title
CY1125032T1 (el) Υποκινητης mnd χιμαιρικους υποδοχεις αντιγονου
MX2018006148A (es) Inhibidores de cxcr2.
EA201891209A1 (ru) Модуляторы хемокиновых рецепторов
BR112016026942A2 (pt) geração de visualizações de direção curva por curva.
BR112017013159A2 (pt) composições de dentifrício com baixo teor de água.
BR112016021012A2 (pt) composições farmacêuticas de compostos terapeuticamente ativos.
SG10201607718SA (en) Diaphragm Wall Excavator
PH12016501252A1 (en) Novel tetrahydropyridopyrimidine compound or salt thereof
DK3234282T3 (da) Seismisk beskyttelsesstruktur til skillevægge
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
TR201901516T4 (tr) Nöroprotektif ajanlar ve bunların kullanımları.
SG11201703991PA (en) System for the generation of call advance data
MY187959A (en) Reactor
TR201909052T4 (tr) Deferasiroks içeren suda dağılabilen tablet formülasyonu.
TR201722910A2 (tr) Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari
ES1177734Y (es) Andamio de fachada.
ITUB20159583A1 (it) Autocombustore di biomassa.
EA201791596A1 (ru) Пиразоловые соединения
EP3177280A4 (en) Synthesis of 2,2,2-trifluoroethanethiol
FI11907U1 (fi) Reaktorirakenne
UA95132U (xx) Пилоосаджувальна камера
UA108340U (uk) Морфолінію 1-н-бутилтеобромін-8-ілтіоацетат, який виявляє діуретичну дію
TH1501005699B (th) สารรองพื้นที่มีน้ำเป็นส่วนผสมหลัก
TR201401768A2 (tr) Miyasteninin tedavisine yönelik bir kompozisyon.
GB201408238D0 (en) Synthesis of substituted 1,2,3-Triazoles